Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td align="left"> </td><td align="center">EORTC (patients)</td><td align="center">OS (months)</td><td align="center">PERCIST (patients)</td><td align="center">OS (months)</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td align="left">CMR</td><td align="center">0</td><td align="center">n.a.</td><td align="center">0</td><td align="center">n.a.</td></tr><tr><td align="left">PMR</td><td align="center">38</td><td align="center">14.2</td><td align="center">34</td><td align="center">14.5</td></tr><tr><td align="left">SMD</td><td align="center">16</td><td align="center">6.4</td><td align="center">20</td><td align="center">6.9</td></tr><tr><td align="left">PMD</td><td align="center">7</td><td align="center">12.2</td><td align="center">7</td><td align="center">12.2</td></tr><tr><td align="left">SMD + PMD</td><td align="center">23</td><td align="center">7.2</td><td align="center">27</td><td align="center">7.9</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Comparison of the two methods to assess the response and overall survival (OS).

Gastroenterology Research and Practice

tab2

Table 2

Table 2: Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review 

Table 2 | Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review 